U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Drug Master Files for Bulk Antibiotic Drug Substances
  1. Search for FDA Guidance Documents

GUIDANCE DOCUMENT

Drug Master Files for Bulk Antibiotic Drug Substances Guidance for Industry November 1999

Download the Final Guidance Document Read the Federal Register Notice
Final
Docket Number:
FDA-1999-D-1314
Issued by:
Guidance Issuing Office
Center for Drug Evaluation and Research

This guidance is intended for those in industry whose approved applications for bulk antibiotic drug substances (i.e., bulk applications) were converted to Type II Drug Master Files (DMFs) when section 507 of the Federal Food, Drug, and Cosmetic Act was repealed as part of the enactment of section 125 of Title I of the Food and Drug Administration Modernization Act on November 21, 1997. This guidance explains the purpose of DMFs, discusses the type of information expected in a Type II DMF, outlines administrative procedures governing review of DMFs, and clarifies your responsibilities as a DMF holder. The information presented in this guidance is also relevant to the submission of new DMFs for bulk antibiotic drug substances.

Submit Comments

Submit Comments Online

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-1999-D-1314.

Back to Top